ClinicalTrials.govpublic full text
Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients
covid-19, covid-19 (sars-cov-2 infection), sars-cov-2 infection, infections, virus diseases, respiratory symptoms, hematopoietic stem cell transplantation, immunocompromised host, pneumonia, hematologic malignancies, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 994511
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.